Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Mise à jour : Il y a 4 ans
Référence : NCT00990314

Femme et Homme

Extrait

This is an open-label study for patients who participated in the BPS-MR-PAH-203 study and have volunteered to continue treatment for PAH with Beraprost Sodium Modified Release (BPS-MR) tablets.


Critère d'inclusion

  • pulmonary arterial hypertension


Liens